Estimation of efficacy of Reduced form of Coenzyme Q10 to seasonal allergy.
Not Applicable
- Conditions
- one
- Registration Number
- JPRN-UMIN000020309
- Lead Sponsor
- imeQ Co. Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients of seasonal allergy. 2. Using medicines such as anti-allergy and steroid. 3. Using Warfarin. 4. Have to use anti-allergy medicine during test periods. 5. Patients of nasal diseases such as nasal catarrh etc. 6. Doctor did not allowed to enrty to this study. 7. Patient of serious desease such as diabetes, liver disease, renal disease, heart disease, immunodeficiency, cancer, anemia, and asthma. Lactating, pregnant and wish to pregnant in this study periods. Use CoQ10 supplement. Entry another clinical study which ongoing or performed within 1 month.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life after 4 months intake.
- Secondary Outcome Measures
Name Time Method